Insulysin hydrolyzes amyloid β peptides to products that are neither neurotoxic nor deposit on amyloid plaques

Journal of Neuroscience

Volumn 20, Issue 23, 2000, Pages 8745-8749

  Mukherjee, A ^a   Song, E S ^a   Kihiko Ehmann, M ^a   Goodman J P , Jr ^a   St Pyrek, J ^a   Estus, S ^a   Hersh, L B ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Amyloid peptide metabolism; A cleavage; A deposition; A neurotoxicity; Insulysin; Metallopeptidase

Indexed keywords

AMYLOID; INSULINASE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; DRUG EFFECT; GENE THERAPY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0034551718     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-23-08745.2000     Document Type: Article

References (27)

1. Alpha-2 macroglobulin is genetically associated with Alzheimer disease
2. A beta deposition inhibitor screen using synthetic amyloid
3. Deposition of soluble amyloid-beta onto amyloid templates: With application for the identification of amyloid fibril extension inhibitors
4. Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant 'apoptotic' pattern of gene induction
5. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease
6. Neutral endopeptidase can hydrolyze beta-amyloid (1-40) but shows no effect on beta-amyloid precursor protein metabolism
7. Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation
8. Identification of the major Abeta1-42 -degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition
9. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP) an apolipoprotein E receptor, with late-onset Alzheimer's disease
10. Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme
11. Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: Involvement of insulin-degrading enzyme
12. Alpha2 macroglobulin complexes with and mediates the endocytosis of beta amyloid peptide via cell surface low-density lipoprotein receptor related protein
13. Degradation of soluble amyloid b-peptides 1-40, 1-42, and the Dutch variant 1-40Q by Insulin-degrading enzyme from Alzheimer disease and control brains
14. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation
15. Gelsolin inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils
16. Identification of gamma-endorphin-generating enzyme as insulin-degrading enzyme
17. Alzheimer's disease: A central role for amyloid
18. Purification and cloning of amyloid precursor protein beta-secretase from human brain
19. Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation
20. Arrest of beta-amyloid fibril formation by a pentapeptide ligand
21. Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger
22. Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations
23. The plasmin system is induced by and degrades amyloid-beta aggregates
24. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE
25. Neurons regulate extracellular levels of amyloid betaprotein via proteolysis by insulin-degrading enzyme
26. Labeling of cerebral amyloid in vivo with a monoclonal antibody
27. Selective inhibition of Abeta fibril formation